Parent Key Opinion Leaders to Increase Demand of Effective Treatments for Youth Anxiety (Project CHAT)
Increasing Parent Demand for Evidence-Based Practices to Treat Youth Anxiety: The Effect of Parent Key Opinion Leaders
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19122
- Temple University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be least 18 years of age
- Be fluent in English
- Be the primary caregiver of a youth aged 5 to 18 years
- Have a child at one of the schools offering a presentation
Exclusion Criteria:
• None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Researcher-Only
The researcher-facilitated presentation, led by two clinical psychology graduate students, will be the same for all schools.
|
The outreach presentation will last 75 minutes with an additional 15 minutes for caregiver questions.
The presentations will occur in the evening via Zoom.
The presentation will include information about identifying anxiety disorders, strategies for caregivers to help their youth with anxiety, evidence-based practices to treat youth anxiety, and strategies for finding a therapist who uses cognitive behavior therapy with exposures.
The text on the presentations is written at a 5.3 grade reading level.
Presentations will incorporate stigma reduction strategies, such as education to dispel myths, and behavioral decision-making tools to elicit hope, empowerment, and motivation.
|
|
Experimental: Key Opinion Leader
The key opinion leader (KOL) co-facilitated presentations will include the same core principles as the researcher-facilitated presentation but may vary by school in terms of specific examples and content emphasized based on KOL feedback.
A caregiver KOL from the local community (selected by the parent teacher association or a similar group) will co-facilitate the presentation with a clinical psychology graduate researcher.
|
The outreach presentation will last 75 minutes with an additional 15 minutes for caregiver questions.
The presentations will occur in the evening via Zoom.
The presentation will include information about identifying anxiety disorders, strategies for caregivers to help their youth with anxiety, evidence-based practices to treat youth anxiety, and strategies for finding a therapist who uses cognitive behavior therapy with exposures.
The text on the presentations is written at a 5.3 grade reading level.
Presentations will incorporate stigma reduction strategies, such as education to dispel myths, and behavioral decision-making tools to elicit hope, empowerment, and motivation.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Pre-Presentation to Post-Presentation in Treatment Seeking Evaluation - Intention to Seek Cognitive Behavioral Therapy
Time Frame: pre-presentation; post-presentation (within 1 week after the presentation)
|
Participants rate how likely they are to seek a therapist who uses exposure therapy for their child in the next three months on a scale ranging from 1 (very unlikely) to 5 (very likely).
|
pre-presentation; post-presentation (within 1 week after the presentation)
|
|
Number of Participants Who Sought Cognitive Behavioral Therapy as Assessed by Treatment Seeking Evaluation - Actual Cognitive Behavioral Therapy Seeking
Time Frame: 3-month follow-up
|
Participants indicate whether they sought exposure therapy for their child since the presentation.
Participants were first ask if they sought therapy for their child.
If yes, they were asked if they sought exposure therapy for their child (options were yes, no, unsure).
The count provided is the number of participants that responded "yes" they sought exposure therapy for their child.
|
3-month follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Pre-Presentation to Post-Presentation in Parent Engagement in Evidence-Based Services Questionnaire, Knowledge Subscale
Time Frame: pre-presentation; post-presentation (within 1 week after the presentation)
|
The Parent Engagement in Evidence-Based Services Questionnaire, Knowledge subscale assesses caregiver perceived understanding of how to seek evidence-based practice.
Participants rate five items on a ranging from 1 (strongly disagree) to 5 (strongly agree).
Items are averaged to create the Parent Engagement in Evidence-Based Services Questionnaire, Knowledge subscale (subscale range = 1-5); higher scores indicate higher levels of perceived knowledge about seeking evidence-based practice.
|
pre-presentation; post-presentation (within 1 week after the presentation)
|
|
Change From Pre-Presentation to Post-Presentation in Therapy Subjective Norms Questionnaire
Time Frame: pre-presentation; post-presentation (within 1 week after the presentation)
|
The Therapy Subjective Norms Questionnaire is a six-item measure of caregiver perception of subjective norms for seeking cognitive behavioral therapy.
Items are rated on a scale ranging from 1 (strongly disagree) to 7 (strongly agree).
Items are summed to create a total score (range = 6 - 42); higher scores indicate more positive subjective norms about seeking therapy.
|
pre-presentation; post-presentation (within 1 week after the presentation)
|
|
Change From Pre-Presentation to Post-Presentation in Caregiver Attitudes About Cognitive Behavioral Therapy
Time Frame: pre-presentation; post-presentation (within 1 week after the presentation)
|
The Caregiver Attitudes about Cognitive Behavioral Therapy includes 18 strategies used in cognitive behavioral therapy for youth anxiety.
Participants rate how helpful they believe each strategy would be for treating their child on a five-point scale ranging from 1 (very unhelpful) to 5 (very helpful).
Items are summed to create a total score (range = 18 - 90); higher scores indicate more favorable attitudes.
|
pre-presentation; post-presentation (within 1 week after the presentation)
|
|
Change From Pre-Presentation to Post-Presentation in Parents' Internalized Stigma of Mental Illness Scale
Time Frame: pre-presentation; post-presentation (within 1 week after the presentation)
|
The Parents' Internalized Stigma of Mental Illness Scale (PISMIS) assesses caregiver perception of internalized stigma for having a youth with a mental illness (Zisman-Ilani et al., 2013).
Participants rate 10 statements on a scale ranging from 1 (strongly disagree) to 4 (strongly agree); some items are reverse scored.
Items are summed to create a total score (range = 10-40); higher scores indicate higher levels of family stigma.
|
pre-presentation; post-presentation (within 1 week after the presentation)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Pre-Presentation to Post-Presentation and to 3-Month Follow-Up in Barriers to Seeking Treatment
Time Frame: pre-presentation; post-presentation (within 1 week after the presentation)
|
The Barriers to Seeking Treatment questionnaire asks participants to indicate whether they agree with 21 potential barriers to treatment (yes/no).
A count of the total number of barriers will be used in analyses.
|
pre-presentation; post-presentation (within 1 week after the presentation)
|
|
Change From Pre-Presentation to 3-Month Follow-Up in Barriers to Seeking Treatment
Time Frame: pre-presentation; 3-month follow-up
|
The Barriers to Seeking Treatment questionnaire asks participants to indicate whether they agree with 21 potential barriers to treatment (yes/no).
A count of the total number of barriers will be used in analyses.
|
pre-presentation; 3-month follow-up
|
|
Client Satisfaction Questionnaire
Time Frame: post-presentation (within 1 week after the presentation)
|
The Client Satisfaction Questionnaire assesses participants' satisfaction with the presentation.
Items are rated on scale ranging from 1 to 4. Items are summed; higher composite scores indicate greater program satisfaction.
|
post-presentation (within 1 week after the presentation)
|
|
Relatability Evaluation
Time Frame: post-presentation (within 1 week after the presentation)
|
The Relatability Evaluation will be used to evaluate participants' impression of the presenter.
Participants will rate each presenter (scale ranging from 1 to 5) on 10 items associated with aspects of key opinion leaders: relatable, likeable, similar, think similarly, similar beliefs, credible, trustworthy, understanding of the local community, familiar, and friendship.
Items are summed; higher composite scores indicate that the presenter is more relatable.
|
post-presentation (within 1 week after the presentation)
|
|
Brief Revised Child Anxiety and Depression Scale-Parent Version
Time Frame: pre-presentation
|
The total anxiety scale (15 items) from the Brief Revised Child Anxiety and Depression Scale-Parent Version will be used to assess youth anxiety (Ebesutani et al., 2017).
Participants rate items on a scale from 0 (never) to 3 (always).
Items are summed; higher scores indicate higher levels of anxiety.
|
pre-presentation
|
|
Demographics
Time Frame: pre-presentation
|
A demographics questionnaire will assess caregiver and youth age, gender, race, ethnicity, and nativity; caregiver level of education, income, and religion; and youth health insurance status.
|
pre-presentation
|
|
Content Checklist
Time Frame: during the 1.5 hour presentation
|
A content checklist will assess the core components of the presentation, as well as presenter and audience member self-disclosure about experiencing receiving therapy for themselves or their child (yes/no).
Self-disclosure will be considered to have been made if either the presenter or an audience member self-discloses about their experiences.
|
during the 1.5 hour presentation
|
|
Qualitative Interview
Time Frame: 3-month follow-up
|
A qualitative interview will ask participants about the following topics: (1) their perception of presenters; (2) ways in which the presenters affected their decision to seek treatment; (3) factors they considered when seeking treatment; (4) strategies they have used from the presentation; (5) their perception of exposure therapy; and (6) general ways that the mental health system could be improved to improve access to therapy.
|
3-month follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Philip C Kendall, Ph.D., Temple University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 26871
- 1F31MH124346-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.